Prabhudas Lilladher has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharma sector. The brokerage house expects Sun Pharma to report net profit at Rs. 837 crore down 36.1% year-on-year (down 32.6% quarter-on-quarter).
Net Sales are expected to increase by 8.1 percent Y-o-Y (down 5.3 percent Q-o-Q) to Rs. 7,252.9 crore, according to Prabhudas Lilladher.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 9.7 percent Y-o-Y (down 24.9 percent Q-o-Q) to Rs. 1,554.9 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Prabhudas Lillader - All Sectors Q4 Estimates
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
